Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$47,918,308
+$5,062,144 QoQ
Shares Held
5,725,007
+20.4% QoQ
Ownership
2.56%
of shares outstanding
% of Portfolio
2.31%
of 13F equity value
Holder Rank
#9
of 317 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Derivatives in ADMA
reported options exposure · as of Jun 30, 2026CallValue
$2,511,000
CallShares
300,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caligan Partners LP holds $1,404,383,722 across 23 Biotechnology names. ADMA ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,961,795 | $367,404,967 | |
| 2 | ABVX |
Abivax S.A.
|
1,557,924 | $207,608,952 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,188,636 | $127,225,410 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,553,262 | $84,512,985 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
2,500,103 | $78,153,219 | |
| 6 | AVTX |
Avalo Therapeutics, Inc.
|
3,163,866 | $58,468,243 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
889,944 | $53,717,019 | |
| 8 | ADMA |
Adma Biologics, Inc.
This page
|
5,725,007 | $47,918,308 |
All Filings in ADMA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,918,308 | 5,725,007 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $2,511,000 | 300,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $42,856,164 | 4,756,511 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $2,703,000 | 300,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $54,948,145 | 3,012,508 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,652,687 | 2,636,609 | Shares | Sole | 2025-11-14 | |
| 2023-12-31 | $2,138,353 | 473,087 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,139,096 | 597,513 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,127,322 | 847,513 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,503,249 | 1,662,613 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,383,240 | 2,676,093 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||